These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8618701)

  • 21. [A case of post-hemiplegic painful dystonia following thalamic infarction with good response to botulinus toxin].
    Motoi Y; Hattori Y; Miwa H; Shina K; Mizuno Y
    Rinsho Shinkeigaku; 1997 Oct; 37(10):881-6. PubMed ID: 9490897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Severe and prolonged dysphagia complicating botulinum toxin A injections for dystonia in Machado-Joseph disease.
    Tuite PJ; Lang AE
    Neurology; 1996 Mar; 46(3):846. PubMed ID: 8618703
    [No Abstract]   [Full Text] [Related]  

  • 23. Tardive dystonia after a short course of thioridazine.
    Giron LT
    J Fam Pract; 1987 Apr; 24(4):405-6. PubMed ID: 3559493
    [No Abstract]   [Full Text] [Related]  

  • 24. Botulinum toxin in otolaryngology: a review of its actions and opportunities for use.
    Neuenschwander MC; Pribitkin EA; Sataloff RT
    Ear Nose Throat J; 2000 Oct; 79(10):788-9, 792, 794 passim. PubMed ID: 11055100
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Botulinum toxin for people with dystonia treated by an outreach nurse practitioner: a comparative study between a home and a clinic treatment service.
    Whitaker J; Butler A; Semlyen JK; Barnes MP
    Arch Phys Med Rehabil; 2001 Apr; 82(4):480-4. PubMed ID: 11295008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A case of painless arms/moving fingers responsive to botulinum toxin a injections.
    Singer C; Papapetropoulos S
    Parkinsonism Relat Disord; 2007 Feb; 13(1):55-6. PubMed ID: 16723267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroleptic withdrawal behavior--cases of rebound cholinergic supersensitivity.
    Inoue F
    Clin Pharm; 1982; 1(6):567-9. PubMed ID: 7185550
    [No Abstract]   [Full Text] [Related]  

  • 28. [Treatment of neurological disorders with botulinum toxin: recent progress].
    Mezaki T; Kaji R
    No To Shinkei; 1997 Jun; 49(6):499-505. PubMed ID: 9198089
    [No Abstract]   [Full Text] [Related]  

  • 29. Botulinum toxin injections for lingual dystonia.
    Blitzer A; Brin MF; Fahn S
    Laryngoscope; 1991 Jul; 101(7 Pt 1):799. PubMed ID: 2062167
    [No Abstract]   [Full Text] [Related]  

  • 30. [Dystonia: therapeutic aspects].
    Papaterra Limongi JC
    Arq Neuropsiquiatr; 1996 Mar; 54(1):147-55. PubMed ID: 8736161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of cervical dystonia with botulinum toxin].
    Gouider-Khouja N; Turki I; Ben Hamida M; Hentati F
    Tunis Med; 1999 Feb; 77(2):101-4. PubMed ID: 10333707
    [No Abstract]   [Full Text] [Related]  

  • 32. Frequency of adverse reactions to prochlorperazine in the ED.
    Olsen JC; Keng JA; Clark JA
    Am J Emerg Med; 2000 Sep; 18(5):609-11. PubMed ID: 10999579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after stroke.
    Jahangir AW; Tan HJ; Norlinah MI; Nafisah WY; Ramesh S; Hamidon BB; Raymond AA
    Med J Malaysia; 2007 Oct; 62(4):319-22. PubMed ID: 18551937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bilateral globus pallidus internus deep brain stimulation in tardive dyskinesia: a case report.
    Eltahawy HA; Feinstein A; Khan F; Saint-Cyr J; Lang AE; Lozano AM
    Mov Disord; 2004 Aug; 19(8):969-72. PubMed ID: 15300668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of general weakness in a patient with amyotrophic lateral sclerosis after focal botulinum toxin injection.
    Mezaki T; Kaji R; Kohara N; Kimura J
    Neurology; 1996 Mar; 46(3):845-6. PubMed ID: 8618702
    [No Abstract]   [Full Text] [Related]  

  • 36. [Laryngeal dystonia. Comparison of transcutaneous and transoral injection of botulinum toxin].
    García Ruiz PJ; Cenjor Español C; Sánchez Pernaute R; Astarloa R; Sánchez Bernardos V; García de Yébenes Prous J
    Neurologia; 1996; 11(6):216-9. PubMed ID: 8768677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variability of the immunologic and clinical response in dystonic patients immunoresistant to botulinum toxin injections.
    Sankhla C; Jankovic J; Duane D
    Mov Disord; 1998 Jan; 13(1):150-4. PubMed ID: 9452341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Botulinum toxin--from threat to cure].
    Odergren T; Lennerstrand G; Lindestad PA; Hertegård S; Borg J
    Lakartidningen; 1996 Apr; 93(17):1619-24. PubMed ID: 8667769
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment of dystonia.
    Adam OR; Jankovic J
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S362-8. PubMed ID: 18267265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of spasmodic dysphonia with botulinum toxin].
    Vilkman E; Laurikainen E; Marttila R
    Duodecim; 1995; 111(16):1546-51. PubMed ID: 9273263
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.